Skip to main content
. 2022 Sep 7;14:977411. doi: 10.3389/fnagi.2022.977411

FIGURE 5.

FIGURE 5

Ubiquitination in Alzheimer’s disease. Ubiquitination of APP by E3 ligase (Stub1) targets it to endosomal degradation. Mutations at lysine residues inhibit the ubiquitination and endosomal degradation of APP increasing the amyloid burden.